MIZORIBINE IMPROVES RENAL TUBULOINTERSTITIAL FIBROSIS IN UNILATERAL URETERAL OBSTRUCTION (UUO)-TREATED RAT BY INHIBITING THE INFILTRATION OF MACROPHAGES AND THE EXPRESSION OF ALPHA-SMOOTH MUSCLE ACTIN
T. Sakai et al., MIZORIBINE IMPROVES RENAL TUBULOINTERSTITIAL FIBROSIS IN UNILATERAL URETERAL OBSTRUCTION (UUO)-TREATED RAT BY INHIBITING THE INFILTRATION OF MACROPHAGES AND THE EXPRESSION OF ALPHA-SMOOTH MUSCLE ACTIN, The Journal of urology, 158(6), 1997, pp. 2316-2322
Purpose: Several lines of evidence suggest that the infiltration of ma
crophages and the expression of alpha-smooth muscle actin in myofibrob
lasts play important roles in the pathogenesis of tubulointerstitial f
ibrosis. However, the temporal sequence of these pathological changes
or the dynamics in the expression of this cytoskeletal molecule in the
process of tubulointerstitial fibrosis have not been precisely docume
nted. Materials and Methods: We investigated the infiltration of macro
phages and the expression of alpha-smooth muscle actin in interstitial
fibrosis caused by a unilateral ureteral obstruction (UUO) experiment
al model. Results: The result showed that the macrophages were immobil
ized at the interstitium and alpha-smooth muscle actin was up-regulate
d in myofibroblasts of both cortex and medulla at day 3 when interstit
ial volume start to increase significantly. The highest expression of
alpha-smooth muscle actin was detected at day 5 and the most intense i
nfiltration of macrophages was noted at day 14 while the interstitial
volume in renal cortex and medulla continued to increase until day 28.
Furthermore, we investigated the effect of mizoribine, an immunosuppr
essive agent, on the interstitial fibrosis induced by UUO, demonstrati
ng that mizoribine, but not prednisolone, significantly improves the t
ubulointerstitial fibrosis by suppressing the macrophage infiltration
and the expression of alpha-smooth muscle actin. Conclusions: We discu
ss the pathological roles of macrophages and alpha-smooth muscle actin
in tubulointerstitial fibrosis induced by UUO treatment. We also emph
asize the pharmacological basis and clinical relevance of mizoribine i
n the treatment of interstitial fibrosis caused by obstructive nephrop
athy.